KING OF PRUSSIA, Pa., Dec. 9 /PRNewswire/ -- Cytokine PharmaSciences, Inc.
today announced the promotion of Vidal F. de la Cruz, Ph.D. to the position of
Vice President, Business Development. Dr. de la Cruz joined the Company in
2001 as Director of Preclinical Development and assumed additional
responsibilities for business development in 2003. He received his B.S. in
biology from Fairleigh Dickinson University and his Ph.D. in cell and
molecular biology from UCLA. Dr. de la Cruz also did post-doctoral work at
the NIH before moving into the biotech industry in 1988.
"This is a well deserved promotion," stated Denny Willson, President and
CEO of Cytokine PharmaSciences. "Vidal has made an important contribution to
our business over the past three years. I look forward to what he can
accomplish in his new role as Vice President of Business Development."
Cytokine PharmaSciences is a biopharmaceutical company located in King of
Prussia, Pennsylvania (near Philadelphia). The company licenses technologies
from academia and other sources, develops products from those technologies and
outlicenses the products to third parties for marketing. For more
information, go to http://www.cytokinepharmasciences.com.
SOURCE Cytokine PharmaSciences, Inc.